Latest New Zealand News

Novatti Group Limited has achieved a key turnaround milestone by reporting positive cash EBITDA of $100k in Q3 FY25, alongside record quarterly revenue of $13.4 million and improved margins in its core Payments AU/NZ business.

Biome Australia is set to expand its Activated Probiotics range with two new products targeting vaginal health and perinatal care, tapping into a booming women’s health supplements market.

PainChek Limited reports strong progress toward FDA De Novo clearance for US market entry, launches its Infant App in Australia, and achieves robust global licence growth with a 30% year-on-year revenue increase.

Pureprofile Limited reported a robust 16% revenue increase in Q3 FY25, driven by strong international expansion and new AI-powered solutions, while reaffirming its FY25 financial guidance.

BauMart Holdings Limited has announced a rights issue to raise approximately $482,000 by offering new shares at a steep discount, aiming to accelerate equipment delivery, fund R&D, and support international recruitment.

Siren Gold has committed to a second deep diamond drillhole at its Sams Creek Project, targeting promising gold mineralisation below the current resource. This move could significantly expand the project’s Mineral Resource Estimate amid rising gold prices.

Cyclone Metals has inked a binding agreement with Vale S.A. for up to USD 138 million to develop its Iron Bear Project in Canada, marking a significant step forward with successful pilot production runs of high-grade iron concentrates and pellets.

MFF Capital Investments Limited has updated its dividend details for the half-year ending December 2024, announcing a fully franked dividend of 8 cents per share and setting reinvestment prices for its DRP and BSP plans.

Cue Energy Resources delivered a robust quarter with production rising to 1,700 boe/d and a $7 million dividend payout, while advancing development projects in Australia and Indonesia.

4DMedical Limited reports a 103% surge in year-to-date revenue, secures major contracts with leading healthcare providers, and advances its CT:VQ™ technology towards FDA clearance.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.

Nova Eye Medical reported a 27% rise in Q3FY25 sales excluding China, driven by record US performance and a sharp reduction in glaucoma segment losses. The company confirmed FY25 revenue guidance and unveiled plans to expand its iTrack™ technology into ocular drug delivery.